Abstract
Background Posttraumatic stress symptoms (PTSS) are commonly experienced in people with chronic pain. Reduced white matter microstructural integrity in the uncinate fasciculus and the cingulum has been reported similarly in chronic pain and PTSD studies separately. However, the relationship between chronic pain, PTSS and white matter integrity remains unclear.
Methods. Thirty-six subjects with and 20 without chronic pain (controls) underwent diffusion weighted imaging and completed the civilian version of the Posttraumatic stress Disorder CheckList (PCL-C). Average fractional anisotropy (FA) and mean diffusivity (MD) values were extracted from three regions-of-interest (uncinate fasciculus, cingulate and hippocampal portions of the cingulum). A series of multiple linear regressions determined the main effects of Group, PTSS severity (PCL-C total score) and their interactions on each ROI separately.
Results. The group-by-PTSS interaction was significantly associated with variations of uncinate fasciculus FA. Moderation analysis indicated that increasing PTSS severity was significantly associated with reduced uncinate fasciculus FA in the control group, but not in chronic pain group. No other significant association was found for any other ROI FA values, and there was no significant association with MD values.
Conclusions. Consistent with previous studies, increasing PTSS levels were associated with reduced FA of the uncinate fasciculus in controls, but not in people with chronic pain. This suggests that different mechanisms may be at play in chronic pain, including the interplay with other psychopathological problems, such as depression and anxiety. Future larger studies of more homogeneous chronic pain conditions are warranted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a project grant from the National Health and Medical Research Council of Australia (ID1084240) and a Rebecca Cooper Fellowship from the Rebecca L. Cooper Medical Research Foundation awarded to S.M.G.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human Research Ethics committees of the University of New South Wales (HC15206) gave ethical approval for this work Human Research Ethics committees of the University of Sydney (HREC06287) gave ethical approval for this work Human Research Ethics committees of the Northern Sydney Local Health District (1102-066M) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
